BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

453 related articles for article (PubMed ID: 17728329)

  • 21. The value of IgA antiphospholipid testing for diagnosis of antiphospholipid (Hughes) syndrome in systemic lupus erythematosus.
    Bertolaccini ML; Atsumi T; Escudero Contreras A; Khamashta MA; Hughes GR
    J Rheumatol; 2001 Dec; 28(12):2637-43. PubMed ID: 11764209
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Significance of antiphospholipid syndrome and antiphospholipid antibodies in patients with systemic lupus erythematosus in estimation of risk of subclinical atherosclerosis development].
    Fischer K; Brzosko M; Walecka A; Ostanek L; Sawicki M
    Pol Arch Med Wewn; 2007; 117 Suppl():13-7. PubMed ID: 18778013
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The BC genotype of the VNTR polymorphism of platelet glycoprotein Ibalpha is overrepresented in patients with recurrent stroke regardless of aspirin therapy.
    Cervera A; Tàssies D; Obach V; Amaro S; Reverter JC; Chamorro A
    Cerebrovasc Dis; 2007; 24(2-3):242-6. PubMed ID: 17630485
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Platelet glycoprotein IIb/IIIa (LeuPro 33) polymorphism in stroke patients].
    Pongrácz E; Tordai A; Csornai M; Nagy Z
    Orv Hetil; 2001 Apr; 142(15):781-5. PubMed ID: 11367863
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Association of C807T, Pl(A), and -5 C/T Kozak genotypes with density of glycoprotein receptors on platelet surface.
    Huang T; Sahud MA
    Thromb Res; 2003; 112(3):147-50. PubMed ID: 14967411
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The 4G/5G polymorphism of the type 1 plasminogen activator inhibitor gene and thrombosis in patients with antiphospholipid syndrome.
    Tàssies D; Espinosa G; Muñoz-Rodríguez FJ; Freire C; Cervera R; Monteagudo J; Maragall S; Escolar G; Ingelmo M; Ordinas A; Font J; Reverter JC
    Arthritis Rheum; 2000 Oct; 43(10):2349-58. PubMed ID: 11037896
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Homocysteine, antiphospholipid antibodies and risk of thrombosis in patients with systemic lupus erythematosus.
    Martínez-Berriotxoa A; Ruiz-Irastorza G; Egurbide MV; Rueda M; Aguirre C
    Lupus; 2004; 13(12):927-33. PubMed ID: 15645748
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prevalence and clinical significance of antiprothrombin antibodies in patients with systemic lupus erythematosus or with primary antiphospholipid syndrome.
    Muñoz-Rodríguez FJ; Reverter JC; Font J; Tàssies D; Cervera R; Espinosa G; Carmona F; Balasch J; Ordinas A; Ingelmo M
    Haematologica; 2000 Jun; 85(6):632-7. PubMed ID: 10870121
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Association of mannose-binding lectin gene polymorphisms with antiphospholipid syndrome, cardiovascular disease and chronic damage in patients with systemic lupus erythematosus.
    Font J; Ramos-Casals M; Brito-Zerón P; Nardi N; Ibañez A; Suarez B; Jiménez S; Tàssies D; García-Criado A; Ros E; Sentís J; Reverter JC; Lozano F
    Rheumatology (Oxford); 2007 Jan; 46(1):76-80. PubMed ID: 16801331
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Gene profiling reveals specific molecular pathways in the pathogenesis of atherosclerosis and cardiovascular disease in antiphospholipid syndrome, systemic lupus erythematosus and antiphospholipid syndrome with lupus.
    Perez-Sanchez C; Barbarroja N; Messineo S; Ruiz-Limon P; Rodriguez-Ariza A; Jimenez-Gomez Y; Khamashta MA; Collantes-Estevez E; Cuadrado MJ; Aguirre MA; Lopez-Pedrera C
    Ann Rheum Dis; 2015 Jul; 74(7):1441-9. PubMed ID: 24618261
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical and functional consequences of platelet membrane glycoprotein polymorphisms.
    Yee DL; Bray PF
    Semin Thromb Hemost; 2004 Oct; 30(5):591-600. PubMed ID: 15497101
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Leiden, G20210A mutations in prothrombin gene and antiphospholipid antibodies in systemic lupus erythematosus and antiphospholipid syndrome].
    Reshetniak TM; Patrushev LI; Stukacheva EA; Miroshnikov AI; Tikhonova TL; Nasonov EL; Alekberova ZS
    Ter Arkh; 2000; 72(5):34-8. PubMed ID: 11109617
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Clinico-immunological aspects of antiphospholipid syndrome].
    Reshetniak TM; Alekberova ZS; Aleksandrova EN
    Vestn Ross Akad Med Nauk; 2003; (7):31-4. PubMed ID: 12934468
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Role of the Fcgamma receptor IIA polymorphism in the antiphospholipid syndrome: an international meta-analysis.
    Karassa FB; Bijl M; Davies KA; Kallenberg CG; Khamashta MA; Manger K; Michel M; Piette JC; Salmon JE; Song YW; Tsuchiya N; Yoo DH; Ioannidis JP
    Arthritis Rheum; 2003 Jul; 48(7):1930-8. PubMed ID: 12847687
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Increased soluble vascular cell adhesion molecule 1 concentrations in patients with primary or systemic lupus erythematosus-related antiphospholipid syndrome: correlations with the severity of thrombosis.
    Kaplanski G; Cacoub P; Farnarier C; Marin V; Grégoire R; Gatel A; Durand JM; Harlé JR; Bongrand P; Piette JC
    Arthritis Rheum; 2000 Jan; 43(1):55-64. PubMed ID: 10643700
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Annexin A5 polymorphism (-1C-->T) and the presence of anti-annexin A5 antibodies in the antiphospholipid syndrome.
    de Laat B; Derksen RH; Mackie IJ; Roest M; Schoormans S; Woodhams BJ; de Groot PG; van Heerde WL
    Ann Rheum Dis; 2006 Nov; 65(11):1468-72. PubMed ID: 16449315
    [TBL] [Abstract][Full Text] [Related]  

  • 37. P-selectin glycoprotein ligand-1 VNTR polymorphisms and risk of thrombosis in the antiphospholipid syndrome.
    Diz-Kucukkaya R; Inanc M; Afshar-Kharghan V; Zhang QE; López JA; Pekcelen Y
    Ann Rheum Dis; 2007 Oct; 66(10):1378-80. PubMed ID: 17545190
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Role of platelet glycoprotein polymorphisms in cardiovascular diseases.
    Meisel C; López JA; Stangl K
    Naunyn Schmiedebergs Arch Pharmacol; 2004 Jan; 369(1):38-54. PubMed ID: 14614592
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antiphospholipid antibody tests: spreading the net.
    Bertolaccini ML; Gomez S; Pareja JF; Theodoridou A; Sanna G; Hughes GR; Khamashta MA
    Ann Rheum Dis; 2005 Nov; 64(11):1639-43. PubMed ID: 15817655
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Cardiovascular risk factors in systemic lupus erythematosus and in antiphospholipid syndrome].
    Sarzi-Puttini P; Atzeni F; Carrabba M
    Minerva Med; 2003 Apr; 94(2):63-70. PubMed ID: 12858154
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.